ProfileGDS4718 / 242548_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 21% 30% 18% 29% 20% 15% 18% 31% 28% 28% 27% 13% 18% 17% 18% 27% 24% 22% 17% 20% 31% 18% 35% 24% 24% 19% 23% 15% 31% 18% 16% 19% 20% 32% 23% 22% 21% 24% 24% 20% 28% 16% 15% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2073521
GSM549102patient 115, normal, homogenized [OPG study]4.5403430
GSM549104patient 119, normal, homogenized [OPG study]4.0456818
GSM549108patient 138, normal, homogenized [OPG study]4.5576629
GSM549119patient 077, normal, homogenized [OPG study]4.15520
GSM549133patient 032, cancer, homogenized [OPG study]3.9344715
GSM549139patient 042, cancer, homogenized [OPG study]4.0420818
GSM549099patient 107, normal, homogenized [OPG study]4.6089231
GSM549109patient 139, normal, homogenized [OPG study]4.4933528
GSM549110patient 046, normal, homogenized [OPG study]4.4675228
GSM549114patient 063, normal, homogenized [OPG study]4.3802727
GSM549122patient 082, normal, homogenized [OPG study]3.9106213
GSM549134patient 033, cancer, homogenized [OPG study]4.0774418
GSM549136patient 036, cancer, homogenized [OPG study]3.9909617
GSM549140patient 044, cancer, homogenized [OPG study]4.0430218
GSM549111patient 047, normal, homogenized [OPG study]4.3783327
GSM549113patient 057, normal, homogenized [OPG study]4.2464424
GSM549132patient 031, cancer, homogenized [OPG study]4.2011222
GSM549137patient 038, cancer, homogenized [OPG study]4.0244217
GSM549142patient 047, cancer, homogenized [OPG study]4.2342120
GSM549100patient 110, normal, homogenized [OPG study]4.5930231
GSM549107patient 135, normal, homogenized [OPG study]4.0472518
GSM549115patient 068, normal, homogenized [OPG study]4.6996835
GSM549116patient 072, normal, homogenized [OPG study]4.2817224
GSM549120patient 078, normal, homogenized [OPG study]4.3104224
GSM549131patient 030, cancer, homogenized [OPG study]4.0493819
GSM549118patient 074, normal, homogenized [OPG study]4.2711823
GSM549129patient 027, cancer, homogenized [OPG study]3.9634215
GSM549123patient 088, normal, homogenized [OPG study]4.5708831
GSM549124patient 006, cancer, homogenized [OPG study]4.111218
GSM549126patient 015, cancer, homogenized [OPG study]3.9956516
GSM549128patient 025, cancer, homogenized [OPG study]4.0649819
GSM549103patient 117, normal, homogenized [OPG study]4.1991920
GSM549117patient 073, normal, homogenized [OPG study]4.6169132
GSM549138patient 041, cancer, homogenized [OPG study]4.252823
GSM549141patient 045, cancer, homogenized [OPG study]4.1518422
GSM549130patient 028, cancer, homogenized [OPG study]4.2005521
GSM549101patient 111, normal, homogenized [OPG study]4.332624
GSM549105patient 128, normal, homogenized [OPG study]4.2974624
GSM549106patient 134, normal, homogenized [OPG study]4.0819320
GSM549112patient 048, normal, homogenized [OPG study]4.4440128
GSM549125patient 011, cancer, homogenized [OPG study]3.9944316
GSM549127patient 024, cancer, homogenized [OPG study]3.9499415
GSM549135patient 035, cancer, homogenized [OPG study]3.8510913